Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,249 public trials 217 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Completed

R-MegaCHOP-ESHAP-BEAM in Patients With High-Risk Aggressive B-Cell Lymphomas

NCT00558220

Conditions
Diffuse Large B-Cell Lymphoma., Follicular Lymphoma Grade III, Hemic and Lymphatic Diseases, +11 more
Locations
  • University Hospital Brno-Bohunice Brno, Czechia
  • Hospital Chomutov Chomutov, Czechia
  • Hospital České Budějovice České Budějovice, Czechia
  • University Hospital Hradec Králové Hradec Králové, Czechia
View Trial Details
Completed

Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma

NCT00556127

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Az. Ospedaliera SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Ospedale Regionale, Divisione di Oncologia, Aosta, Italy
  • Azienda Ospedaliera Ospedale Policlinico Consorziale Bari, Italy
  • Osp. degli Infermi Biella, Italy
View all 14 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas

NCT03984448

Conditions
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Diffuse Large B-cell Lymphoma, Double-Expressor Lymphoma, +16 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 635 locations
View Trial Details
Active, Not Recruiting

A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma

NCT05421663

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • City of Hope Duarte, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • University of Iowa Hospital and Clinics Iowa City, Iowa, United States
  • University of Kentucky Medical Center Lexington, Kentucky, United States
View all 32 locations
View Trial Details
Active, Not Recruiting

A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies

NCT03888105

Conditions
B-cell Non-Hodgkin Lymphoma (B-NHL), Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Tufts Medical Center Boston, Massachusetts, United States
View all 119 locations
View Trial Details
Active, Not Recruiting

Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia

NCT06323447

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Diffuse Large B Cell Lymphoma, +18 more
Locations
  • University of Hawaii Cancer Center Honolulu, Hawaii, United States
  • Norton Healthcare Cancer Center Louisville, Kentucky, United States
  • Massachussetts General Hospital Boston, Massachusetts, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details

Related conditions